MoneyWorks4Me

Parmax Pharma informs about certificate

30 Oct 2023 Evaluate

Parmax Pharma has informed that it enclosed a Certificate dated 3rd October, 2023 under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2023 received from Purva Shregistey India, Registrar and Share Transfer Agent of the company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..